Constant bloating, cramps, and unpredictable bathroom trips made everyday activities stressful
Participants in the oral semaglutide arm underwent a dose-escalation schedule (3 mg daily for 4 weeks, followed by 7 mg daily for 4 weeks, then 14 mg daily for the remainder of the trial) to minimize gastrointestinal side effects
Compounded tirzepatide is not FDA-approved (the active ingredient is FDA-approved under brand names Mounjaro and Zepbound)
Metabolic Evidence of Diminished Lipid Oxidation in Women with Polycystic Ovary Syndrome
Semaglutide mimics this hormone, telling your brain you are full, slowing down how fast your stomach empties, and enhancing insulin production
Glutathione-based IV infusion therapy may assist in managing oxidative stress and supporting skin vitality under medical supervision